OptiBiotix Health Plc (AIM:OPTI)

Revenue by Segment

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Nov 30, 2018	Nov 30, 2017	Nov 30, 2016
Identifying and Developing Microbial Strains, Compounds and Formulations	1.17M	870.00K	644.00K	457.00K	2.21M
Identifying and Developing Microbial Strains, Compounds and Formulations Growth	34.02%	35.09%	40.92%	-79.35%	45.28%
Total	1.17M	870.00K	644.00K	457.00K	2.21M
Total Growth	34.02%	35.09%	40.92%	-79.35%	45.28%

Revenue by Geography

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Nov 30, 2018	Nov 30, 2017	Nov 30, 2016
United Kingdom	315.00K	330.00K	221.00K	136.00K	648.00K
United Kingdom Growth	-4.55%	49.32%	62.50%	-79.01%	75.19%
Unites States of America	354.00K	141.00K	202.00K	100.00K	827.00K
Unites States of America Growth	151.06%	-30.20%	102.00%	-87.91%	26.35%
India	160.00K	171.00K	-	61.00K	-
India Growth	-6.43%	-	-	-	-
China	68.00K	133.00K	75.00K	-	-
China Growth	-48.87%	77.33%	-	-	-
Rest of World	268.00K	95.00K	146.00K	160.00K	738.00K
Rest of World Growth	182.11%	-34.93%	-8.75%	-78.32%	47.95%
Total	1.17M	870.00K	644.00K	457.00K	2.21M
Total Growth	33.91%	35.09%	40.92%	-79.35%	45.28%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 16, 2026

Data Sources Report a data error